Blog

Jul 22, 2023

RNF41 reverses liver fibrosis

You can also search for this author in PubMed Google Scholar Chronic liver disease is characterized by declining hepatic function, caused by chronic inflammation or insult to the liver resulting in

You can also search for this author in PubMed Google Scholar

Chronic liver disease is characterized by declining hepatic function, caused by chronic inflammation or insult to the liver resulting in progressive deposition of fibrous tissue. There are currently no curative therapies except for organ transplantation, which requires lifelong immunosuppression.

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$29.99 / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

$189.00 per year

only $15.75 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41573-023-00125-6

Moreno-Lanceta, A. et al. RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration. Sci. Transl Med. 15, eabq6225 (2023)

Article PubMed Google Scholar

Download references

An Associate Specialist position is available in the Immunogenetics and Transplantation Laboratory (ITL, https://itl.ucsf.edu/) at the UCSF

San Francisco, California

University of California San Francisco

Houston, Texas (US)

Baylor College of Medicine (BCM)

Houston, Texas (US)

Baylor College of Medicine (BCM)

Join Boehringer Ingelheim as a Postdoctoral researcher and be a part of our vibrant scientific community. Apply with your scientific proposal today!

Biberach an der Riß, Baden-Württemberg (DE)

Boehringer Ingelheim International GmbH

Seeking talents around the world.

Guangzhou, Guangdong, China

Guangzhou Medical University